Andrew D. Patterson, Peter J. Turnbaugh  Cell Metabolism 

Slides:



Advertisements
Similar presentations
Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart Moshi Song, Gerald W. Dorn Cell Metabolism Volume 21, Issue.
Advertisements

Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome Corinne Ferrier Maurice, Henry Joseph Haiser, Peter James Turnbaugh.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Lipin-1 Regulates Autophagy Clearance and Intersects with Statin Drug Effects in Skeletal Muscle Peixiang Zhang, M. Anthony Verity, Karen Reue Cell Metabolism.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Oxygen Sensors at the Crossroad of Metabolism Julián Aragonés, Peter Fraisl, Myriam Baes, Peter Carmeliet Cell Metabolism Volume 9, Issue 1, Pages
A Helping Hand for Cytochrome P450 Enzymes
Obesity and the Microbiota
Dual regulation of the LDL receptor—Some clarity and new questions
Chapter 08 The T Cell Receptor: Proteins and Genes
Elaine Holmes, Jia V. Li, Julian R. Marchesi, Jeremy K. Nicholson 
Systematic Characterization and Analysis of the Taxonomic Drivers of Functional Shifts in the Human Microbiome  Ohad Manor, Elhanan Borenstein  Cell Host.
Volume 25, Issue 3, Pages (March 2017)
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Ticking in Place for the Microbiome to Message Out
Boosting Bacterial Metabolism to Combat Antibiotic Resistance
Homing in on bile acid physiology
Can Your Microbiome Tell You What to Eat?
Peter Libby, Andrew H. Lichtman, Göran K. Hansson  Immunity 
Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
SCFAs Take a Toll En Route to Metabolic Syndrome
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Volume 23, Issue 3, Pages (March 2016)
Microbial Modulation of Insulin Sensitivity
Antibiotic Exposure Promotes Fat Gain
Type 3 Deiodinase in Hypoxia: To Cool or to Kill?
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
Volume 15, Issue 1, Pages (January 2012)
Dysfunctional Families: Clostridium scindens and Secondary Bile Acids Inhibit the Growth of Clostridium difficile  K. Leigh Greathouse, Curtis C. Harris,
Metformin Joins Forces with Microbes
Nitzan Koppel, Emily P. Balskus  Cell Chemical Biology 
Vitamin B12 as a Modulator of Gut Microbial Ecology
The CAMplexities of Central Ghrelin
Treating Obesity? It's in the Bag!
Heike Döppler, Peter Storz  Cell Metabolism 
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Autophagy: A Sweet Process in Diabetes
Volume 24, Issue 1, Pages (July 2016)
Volume 23, Issue 6, Pages (June 2016)
Chad M. Trent, Martin J. Blaser  Cell Metabolism 
It’s in the Milk: Feeding the Microbiome to Promote Infant Growth
Branching Out for Detection of Type 2 Diabetes
Another Shp on the Horizon for Bile Acids
Beyond Energy Homeostasis: the Expanding Role of AMP-Activated Protein Kinase in Regulating Metabolism  David Carling, Benoit Viollet  Cell Metabolism 
Microbes, Microbiota, and Colon Cancer
Obesity and the Microbiota
Ruth E. Ley, Daniel A. Peterson, Jeffrey I. Gordon  Cell 
Volume 7, Issue 1, Pages (April 2014)
Oihane Garcia-Irigoyen, Antonio Moschetta  Cell Metabolism 
Adil Mardinoglu, Jan Boren, Ulf Smith  Cell Metabolism 
Type 3 Deiodinase in Hypoxia: To Cool or to Kill?
Metformin, Microbes, and Aging
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance  Ankur Singh, Ilana Brito, Jan Lammerding 
An Invitation to the Marriage of Metagenomics and Metabolomics
Speaking from the Heart: Systemic Copper Signaling
Microbial Molecules from the Multitudes within Us
Asthma Prevention: Right Bugs, Right Time?
Andrew L. Goodman, Jeffrey I. Gordon  Cell Metabolism 
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Linking DNA Damage, NAD+/SIRT1, and Aging
Adiponectin: Starving for Attention
Homing in on bile acid physiology
CHO Cells Can Make More Protein
Tipping the Energy Balance toward Longevity
Human Microbiota-Associated Mice: A Model with Challenges
One Small Step for Muscle: A New Micropeptide Regulates Performance
AMPK and p53 help cells through lean times
Fig. 3 Postnatal assembly of the humanized gut microbiota.
Presentation transcript:

Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology  Andrew D. Patterson, Peter J. Turnbaugh  Cell Metabolism  Volume 20, Issue 5, Pages 761-768 (November 2014) DOI: 10.1016/j.cmet.2014.07.002 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Biochemical Individuality Viewed through the Lens of Microbial Community Structure (A) The percentage of individuals categorized as “normal” declines rapidly as multiple species-level phylotypes are considered. Expected values were calculated using the formula 0.95N where N is the number of phylotypes. (B) Similar trends were observed at taxonomic levels from phylum to genus. Cell Metabolism 2014 20, 761-768DOI: (10.1016/j.cmet.2014.07.002) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Challenges and Complications to Our Understanding of Microbial Metabolism (A) Limited understanding of the links between microbial ecology (i.e., membership of a given community, the relative abundance of each member, and their gene content) and metabolic activity (the functional output of a given microbial community). (B) Microbial (red), host (dark blue), and abiotic/environmental (green) factors that are predicted to alter microbial xenobiotic metabolism. Cell Metabolism 2014 20, 761-768DOI: (10.1016/j.cmet.2014.07.002) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Microbiome-Dependent Mechanisms May Alter the Metabolic Outcomes of Diverse Therapeutics Examples include (A) the cardiac drug simvastatin, (B) the antipsychotic olanzapine, (C) the diabetes medication metformin, and (D) the antioxidant tempol. Abbreviations: Akkermansia muciniphila (Akk), AMP-activated protein kinase (AMPK), Bacteroidetes (Bact), β-muricholic acid (βMCA), Farnesoid X receptor (FXR), Firmicutes (Firm), glucose (Glc), gut microbiota (GM), 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR), low-density lipoprotein (LDL), primary bile acids (1° BA), secondary bile acids (2° BA), and tauro-β-muricholic acid (TβMCA). Cell Metabolism 2014 20, 761-768DOI: (10.1016/j.cmet.2014.07.002) Copyright © 2014 Elsevier Inc. Terms and Conditions